Latest in Record High Drug
Sort by
527 items
-
Top stories - The New York Times
Supreme Court Leans Toward Truck Driver Fired Over Drug Test
The driver, Douglas Horn, sued the maker of a product said to be free of THC under a federal racketeering law, saying he had suffered a business injury.October 15 -
Top stories - BBC News
Prison gangs: ‘I've chopped people, attacked staff, hidden drugs’
The BBC finds gang warfare in jails is rife, and lack of space makes it difficult to keep rivals apart.October 15 -
Business - CNBC
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.October 15 -
Top stories - BBC News
Will weight-loss drugs help jobless get back into work?
Ministers are lauding the new generation of weight-loss drugs - but are they really the solution?October 15 -
Business - CNBC
Asian semiconductor stocks rise after shares of AI chip darling Nvidia hit a record high
Nvidia's gains in share price lifted its market value to top $3.4 trillion, unseating Microsoft as the second most valuable company on Wall Street.October 15 -
World - Financial Times
Labour donor to back Tortoise’s proposed purchase of Observer
South African businessman Gary Lubner in talks on taking minority stake in online start-upOctober 15 -
World - Financial Times
‘800lb gorilla’: luxury brands battle China’s hit grey-market app
Sales of top brands on DeWu make up estimated 70% of country’s grey market as consumers hunt for lower pricesOctober 15 - China -
Politics - The Hill
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...October 14 -
Business - MarketWatch
Nvidia’s stock secures first record in four months as customers seem locked in
One analyst says customers are in a “prisoner’s dilemma” that will keep them spending, while another was encouraged by recent Nvidia commentary on the company’s “moat.”October 14 -
Business - MarketWatch
Amgen’s stock falls as analyst warns that hype around obesity drug is baked in
Truist analyst Srikripa Devarakonda backs away from bullish call as competition mutes potential for biotech’s drug pipeline.October 14 -
Business - Financial Times
Demis Hassabis’s drug discovery start-up accelerates spending to ‘solve’ diseases
Losses widen at Isomorphic Labs, as new Nobel Prize winner pushes forward with effort to use AI in healthcareOctober 14 -
World - Financial Times
US banks ride ‘soft landing’ high
JPMorgan Chase and Wells Fargo beat forecasts as consumers prove more resilient than fearedOctober 14 -
Top stories - BBC News
Flood defences 'in worst state on record'
The floods minister says she will spend millions on repairs, as victims tell of a "national crisis".October 14